188 related articles for article (PubMed ID: 20651981)
1. Proprotein convertase inhibition results in decreased skin cell proliferation, tumorigenesis, and metastasis.
Bassi DE; Zhang J; Cenna J; Litwin S; Cukierman E; Klein-Szanto AJ
Neoplasia; 2010 Jul; 12(7):516-26. PubMed ID: 20651981
[TBL] [Abstract][Full Text] [Related]
2. Enhanced aggressiveness of benzopyrene-induced squamous carcinomas in transgenic mice overexpressing the proprotein convertase PACE4 (PCSK6).
Bassi DE; Cenna J; Zhang J; Cukierman E; Klein-Szanto AJ
Mol Carcinog; 2015 Oct; 54(10):1122-31. PubMed ID: 24845697
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the prohormone convertase subtilisin-kexin isoenzyme-1 induces apoptosis in human melanoma cells.
Weiß N; Stegemann A; Elsayed MAT; Schallreuter KU; Luger TA; Loser K; Metze D; Weishaupt C; Böhm M
J Invest Dermatol; 2014 Jan; 134(1):168-175. PubMed ID: 23884247
[TBL] [Abstract][Full Text] [Related]
4. Enhanced UV-induced skin carcinogenesis in transgenic mice overexpressing proprotein convertases.
Fu J; Bassi DE; Zhang J; Li T; Cai KQ; Testa CL; Nicolas E; Klein-Szanto AJ
Neoplasia; 2013 Feb; 15(2):169-79. PubMed ID: 23441131
[TBL] [Abstract][Full Text] [Related]
5. Proprotein convertase inhibition promotes ciliated cell differentiation - a potential mechanism for the inhibition of Notch1 signalling by decanoyl-RVKR-chloromethylketone.
Lee SN; Choi IS; Kim HJ; Yang EJ; Min HJ; Yoon JH
J Tissue Eng Regen Med; 2017 Sep; 11(9):2667-2680. PubMed ID: 27878968
[TBL] [Abstract][Full Text] [Related]
6. Proprotein convertase inhibition: Paralyzing the cell's master switches.
Klein-Szanto AJ; Bassi DE
Biochem Pharmacol; 2017 Sep; 140():8-15. PubMed ID: 28456517
[TBL] [Abstract][Full Text] [Related]
7. Inhibition and transcriptional silencing of a subtilisin-like proprotein convertase, PACE4/SPC4, reduces the branching morphogenesis of and AQP5 expression in rat embryonic submandibular gland.
Akamatsu T; Azlina A; Purwanti N; Karabasil MR; Hasegawa T; Yao C; Hosoi K
Dev Biol; 2009 Jan; 325(2):434-43. PubMed ID: 19013448
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of proprotein convertases: approaches to block squamous carcinoma development and progression.
de Cicco RL; Bassi DE; Benavides F; Conti CJ; Klein-Szanto AJ
Mol Carcinog; 2007 Aug; 46(8):654-9. PubMed ID: 17440928
[TBL] [Abstract][Full Text] [Related]
9. Multi-Leu PACE4 Inhibitor Retention within Cells Is PACE4 Dependent and a Prerequisite for Antiproliferative Activity.
Couture F; Ly K; Levesque C; Kwiatkowska A; Ait-Mohand S; Desjardins R; Guérin B; Day R
Biomed Res Int; 2015; 2015():824014. PubMed ID: 26114115
[TBL] [Abstract][Full Text] [Related]
10. PACE4 expression in mouse basal keratinocytes results in basement membrane disruption and acceleration of tumor progression.
Bassi DE; Lopez De Cicco R; Cenna J; Litwin S; Cukierman E; Klein-Szanto AJ
Cancer Res; 2005 Aug; 65(16):7310-9. PubMed ID: 16103082
[TBL] [Abstract][Full Text] [Related]
11. Paired Basic Amino Acid-cleaving Enzyme 4 (PCSK6): An Emerging New Target Molecule in Human Melanoma.
Weishaupt C; Mastrofrancesco A; Metze D; Kemper B; Stegemann A; Picardo M; Klein-Szanto AJP; Böhm M
Acta Derm Venereol; 2020 May; 100(10):adv00157. PubMed ID: 32449780
[TBL] [Abstract][Full Text] [Related]
12. The proprotein convertases furin and PACE4 play a significant role in tumor progression.
Bassi DE; Mahloogi H; Klein-Szanto AJ
Mol Carcinog; 2000 Jun; 28(2):63-9. PubMed ID: 10900462
[TBL] [Abstract][Full Text] [Related]
13. Macrocyclization of a potent PACE4 inhibitor: Benefits and limitations.
Łepek T; Kwiatkowska A; Couture F; Ly K; Desjardins R; Dory Y; Prahl A; Day R
Eur J Cell Biol; 2017 Aug; 96(5):476-485. PubMed ID: 28483279
[TBL] [Abstract][Full Text] [Related]
14. Role of proprotein convertases in prostate cancer progression.
Couture F; D'Anjou F; Desjardins R; Boudreau F; Day R
Neoplasia; 2012 Nov; 14(11):1032-42. PubMed ID: 23226097
[TBL] [Abstract][Full Text] [Related]
15. Proprotein convertases blockage up-regulates specifically metallothioneins coding genes in human colon cancer stem cells.
Gerovska D; García-Gallastegi P; Descarpentrie J; Crende O; Casado-Andrés M; Martín A; Eguia J; Khatib AM; Araúzo-Bravo MJ; Badiola I
Biochim Biophys Acta Mol Cell Res; 2021 Mar; 1868(3):118912. PubMed ID: 33249002
[TBL] [Abstract][Full Text] [Related]
16. PACE4 is an important driver of ZR-75-1 estrogen receptor-positive breast cancer proliferation and tumor progression.
Panet F; Couture F; Kwiatkowska A; Desjardins R; Guérin B; Day R
Eur J Cell Biol; 2017 Aug; 96(5):469-475. PubMed ID: 28347547
[TBL] [Abstract][Full Text] [Related]
17. Subtilisin-like proprotein convertase paired basic amino acid-cleaving enzyme 4 is required for chondrogenic differentiation in ATDC5 cells.
Yuasa K; Futamatsu G; Kawano T; Muroshita M; Kageyama Y; Taichi H; Ishikawa H; Nagahama M; Matsuda Y; Tsuji A
FEBS J; 2012 Nov; 279(21):3997-4009. PubMed ID: 22925071
[TBL] [Abstract][Full Text] [Related]
18. Malignant conversion of non-tumorigenic murine skin keratinocytes overexpressing PACE4.
Mahloogi H; Bassi DE; Klein-Szanto AJ
Carcinogenesis; 2002 Apr; 23(4):565-72. PubMed ID: 11960907
[TBL] [Abstract][Full Text] [Related]
19. Transgenic overexpression of the proprotein convertase furin enhances skin tumor growth.
Fu J; Bassi DE; Zhang J; Li T; Nicolas E; Klein-Szanto AJ
Neoplasia; 2012 Apr; 14(4):271-82. PubMed ID: 22577343
[TBL] [Abstract][Full Text] [Related]
20. Selective inhibition of proprotein convertases represses the metastatic potential of human colorectal tumor cells.
Scamuffa N; Siegfried G; Bontemps Y; Ma L; Basak A; Cherel G; Calvo F; Seidah NG; Khatib AM
J Clin Invest; 2008 Jan; 118(1):352-63. PubMed ID: 18064302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
